検索結果

hereinafter: Mochida) and licensed to Senju as an eye drop treatment for Dry Eye Disease (DED). We are pleased to announce today that it has been applied for manufacturing and marketing approval in J...

Over-The-Counter Medicines | Business Activities | About Senju | SENJU Pharmaceutical

d our energies to the timely development of contact lens products to meet the rising demand in this area. These as well as the other consumer products we manufacture have been carefully developed to s...

Medical devices and healthcare | Business Activities | About Senju | SENJU Pharmaceutical

We will contribute to medical care and your health requirements in the new era through medical devices. Today, in the era of the 100-year-life, digital transformation is being promoted in various fiel...

研究開発の取り組み | 千寿製薬株式会社

R & D activities Product Development Policy Research and Development System R & D Pipeline Clinical trial information Publications Meetings of the Minds Business Collaboration Inquiries licens

お知らせ | 千寿製薬株式会社

December 22, 2025 Obtained manufacturing and marketing approval in Japan for Avarept® Ophthalmic suspension 0.3%, a novel treatment of Dry Eye Disease through Transient Receptor Potential cation chann...